Earn CME: https://www.naccme.com/program/19-cpc-101-7 This webcast features a presentation by Dr. Gary H. Lyman that examines the potential benefits of incorporating biosimilars into oncology clinical pathways. © 2019 NACCME, an HMP Company
Biosimilars and Oncology Clinical Pathways: Perfect Together
